Literature DB >> 34321077

Coronavirus-disease-2019-induced antiphospholipid-like syndrome: a case report.

Fatemeh Bahramnezhad1,2, Banafsheh Ghorbani3, Meysam Ghaedrahamt4, Hamidreza Jamaati5.   

Abstract

BACKGROUND: This paper describes a case of antiphospholipid syndrome-like condition caused by coronavirus disease 2019. The medical community still faces many diagnostic and therapeutic challenges vis-à-vis coronavirus disease 2019. Ultimately, coronavirus disease 2019 is diagnosed on the basis of laboratory and radiological findings. Considering the high rate of mortality due to coagulation abnormalities and thrombosis among coronavirus disease 2019 patients, it is important to pay attention to the differential diagnoses of coronavirus disease 2019 and other diseases following thrombotic events. CASE DESCRIPTION: The patient was a 56-year-old Iranian man who underwent coronary artery bypass graft surgery and mitral valve repair. During hospitalization, the patient showed an elevated level of anticardiolipin antibody (immunoglobulin G isotype), antiphospholipid antibodies, and thrombosis in the brachial artery of the left hand, based on which a differential diagnosis of antiphospholipid syndrome was made. However, ultimately, the coronavirus disease 2019 polymerase chain reaction test and computed tomography scan of the lungs showed that the patient had coronavirus disease 2019.
CONCLUSION: According to the few studies performed on coronavirus disease 2019 patients, elevated levels of the isotypes of antiphospholipid antibodies in coronavirus disease 2019 patients create conditions similar to antiphospholipid syndrome, which, in the absence of reliable coronavirus disease 2019 testing, can lead to misdiagnosis and consequently delayed or improper treatment. Therefore, to provide timely and appropriate treatment, it is important to pay attention to differential diagnosis.
© 2021. The Author(s).

Entities:  

Keywords:  Antibodies; Antiphospholipid; Antiphospholipid syndrome; COVID-19

Mesh:

Substances:

Year:  2021        PMID: 34321077     DOI: 10.1186/s13256-021-02966-4

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  4 in total

1.  Are Pediatric Infections with Lophomonas blattarum Being Missed?

Authors:  Tanu Singhal
Journal:  Indian J Pediatr       Date:  2020-12-11       Impact factor: 1.967

2.  How Much Weight Loss is Required for Cardiovascular Benefits? Insights From a Metabolic Surgery Matched-cohort Study.

Authors:  Ali Aminian; Alexander Zajichek; Chao Tu; Kathy E Wolski; Stacy A Brethauer; Philip R Schauer; Michael W Kattan; Steven E Nissen
Journal:  Ann Surg       Date:  2020-10       Impact factor: 12.969

3.  Antiphospholipid Antibodies in Critically Ill Patients With COVID-19.

Authors:  Meng Xiao; Yan Zhang; Shulan Zhang; Xuzhen Qin; Peng Xia; Wei Cao; Wei Jiang; Huan Chen; Xin Ding; Hua Zhao; Hongmin Zhang; Chunyao Wang; Jing Zhao; Xuefeng Sun; Ran Tian; Wei Wu; Dong Wu; Jie Ma; Yu Chen; Dong Zhang; Jing Xie; Xiaowei Yan; Xiang Zhou; Zhengyin Liu; Jinglan Wang; Bin Du; Yan Qin; Peng Gao; Minya Lu; Xin Hou; Xian Wu; Huadong Zhu; Yingchun Xu; Wen Zhang; Taisheng Li; Fengchun Zhang; Yongqiang Zhao; Yongzhe Li; Shuyang Zhang
Journal:  Arthritis Rheumatol       Date:  2020-10-07       Impact factor: 15.483

  4 in total
  1 in total

1.  A novel case of lupus nephritis and mixed connective tissue disorder in a COVID-19 patient.

Authors:  Sajjad Ali; Talal Almas; Ujala Zaidi; Farea Ahmed; Sufyan Shaikh; Fathema Shaikh; Rida Tafveez; Maaz Arsalan; Ishan Antony; Meetty Antony; Burhanuddin Tahir; Abdullahi T Aborode; Murtaza Ali; Vikneswaran Raj Nagarajan; Arjun Samy; Maen Monketh Alrawashdeh; Maha Alkhattab; Joshua Ramjohn; Jeremy Ramjohn; Helen Huang; Qassim Shah Nawaz; Kashif Ahmad Khan; Shane Khullar
Journal:  Ann Med Surg (Lond)       Date:  2022-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.